On Thursday, the Governor of Kansas, Laura Kelly, said that if the state lawmakers sent a bill seeking to legalize marijuana to her desk, there is a possibility that she would sign it into law.
Speaking about the legislative priorities for 2020 in several interviews, Gov. Kelly said that the lawmakers should legalize medical marijuana as it would help Kansas families whose children are suffering from serious ailments. Medical marijuana would also help in fighting the opioid crisis by reducing the use of prescription pain medication.
Although Gov. Kelly said that she is not in favor of legalizing adult-use marijuana, she also noted that if the legislation were to advance in the state, she would enact it.
Speaking to WIBW, Kelly said that she has not made a decision on what she would do, but her decision would rely on the wants of her people; if the residents of Kansas want it, and the legislature approves it, then she would most likely sign it.
The governor further stressed that her agenda for the 2020 legislative sessions is the legalization of marijuana for medical purposes.
Kelly further said that she wants medical marijuana to be well regulated and controlled so that it does not become the gateway for the legalization of marijuana. She also said that her wish is for medical marijuana to be viewed as a pharmaceutical and controlled product.
She added and said that medical marijuana should be legalized and because of its medicinal potential, families with kids suffering from Dravet syndrome could use it. Children with Dravet syndrome experience severe and frequent epileptic seizures, which could be managed using medical cannabis.
Gov. Kelly has been outspoken about her support for medical marijuana, as it was also part of her 2018 election campaign; however, it is essential to note that she is not at all enthusiastic about recreational marijuana legalization. Kelly said that she does not think the state of Kansas is ready for adult-use marijuana, but a recent survey shows that the majority of Kansas residents are in favor of the marijuana reform.
The survey, which was released in December 2019, showed that 63 percent of the state’s residents are in support of recreational marijuana legalization. This indicates that the task remains on the legislature to approve the legislation and forward it to the Governor’s desk.
The likelihood of legalizing medical marijuana in Kansas is looking up. Last year, a special legislative commission issued recommendations in support of developing a limited medical cannabis program. The program would give patients a chance to access medical marijuana products that are neither smoked nor vaped. The commission also recommended providing patients visiting from out of state with some form of legal protection.
In an interview with KSNT, Gov. Kelly said that she is aware that people have a desire for medical marijuana legalization and that she fully supports it and hopes that the legislature would approve it.
The marijuana industry, including Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and SinglePoint Inc. (OTCQB: SING), is most likely glad that things are looking up for the future of the industry in Kansas.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.